We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$982M
AUM Growth
+$77.1M
Cap. Flow
+$15.2M
Cap. Flow %
1.55%
Top 10 Hldgs %
45.19%
Holding
710
New
276
Increased
121
Reduced
95
Closed
168

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$76.4M
2
PFE icon
Pfizer
PFE
+$45.1M
3
URI icon
United Rentals
URI
+$38.7M
4
TSM icon
TSMC
TSM
+$34.1M
5
AMZN icon
Amazon
AMZN
+$12.8M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$179M
2
APTV icon
Aptiv
APTV
+$89.5M
3
CRM icon
Salesforce
CRM
+$21.7M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10.5M
5
SLV icon
iShares Silver Trust
SLV
+$6.83M

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Technology 15.33%
3 Industrials 7.88%
4 Financials 6.49%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTGT icon
301
TechTarget
TTGT
$278M
$454K 0.05%
4,746
KBR icon
302
KBR
KBR
$4.85B
$453K 0.05%
+9,507
New +$420K
APPF icon
303
AppFolio
APPF
$7.04B
$451K 0.05%
+3,728
New +$472K
TPL icon
304
Texas Pacific Land
TPL
$24.1B
$450K 0.05%
3,240
BX icon
305
Blackstone
BX
$111B
$448K 0.05%
3,459
-4,949
-59% -$660K
PANW icon
306
Palo Alto Networks
PANW
$312B
$447K 0.05%
4,812
-528
-10% -$45.7K
VRTX icon
307
Vertex Pharmaceuticals
VRTX
$135B
$446K 0.05%
2,031
-2,396
-54% -$466K
DRI icon
308
Darden Restaurants
DRI
$24.6B
$445K 0.05%
+2,953
New +$437K
CGBD icon
309
Carlyle Secured Lending
CGBD
$765M
$444K 0.05%
+32,323
New +$448K
AAPL icon
310
PUT
Apple
AAPL
$4.46T
$443K 0.05%
+2,500
New +$395K
OPI
311
DELISTED
Office Properties Income Trust
OPI
$438K 0.04%
+17,641
New +$453K
VLO icon
312
Valero Energy
VLO
$90.3B
$437K 0.04%
5,814
+2,394
+70% +$178K
MGRC icon
313
McGrath RentCorp
MGRC
$2.93B
$435K 0.04%
+5,425
New +$419K
AIV
314
Aimco
AIV
$374M
$433K 0.04%
56,038
-29,592
-35% -$226K
WK icon
315
Workiva
WK
$3.6B
$433K 0.04%
3,318
+1,274
+62% +$180K
CYTK icon
316
Cytokinetics
CYTK
$10.4B
$432K 0.04%
+9,486
New +$366K
AXP icon
317
American Express
AXP
$228B
$426K 0.04%
+2,602
New +$444K
CLNE icon
318
Clean Energy Fuels
CLNE
$344M
$425K 0.04%
+69,397
New +$544K
EBF icon
319
Ennis
EBF
$561M
$425K 0.04%
21,785
KMX icon
320
CarMax
KMX
$8.37B
$422K 0.04%
+3,241
New +$454K
SLG icon
321
SL Green Realty
SLG
$3.89B
$422K 0.04%
+5,709
New +$420K
NET icon
322
Cloudflare
NET
$108B
$419K 0.04%
+3,188
New +$534K
CDR
323
DELISTED
Cedar Realty Trust, Inc
CDR
$414K 0.04%
16,472
F icon
324
CALL
Ford
F
$56B
$413K 0.04%
20,000
PR
325
Permian Resources
PR
$17.6B
$413K 0.04%
69,026
+9,786
+17% +$66.7K

Similar funds

Caxton Associates (New York)'s Q4 2021 Portfolio in Review

As of Q4 2021, Caxton Associates (New York) held 710 positions worth $982M, up 8.5% from $905M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Caxton Associates (New York)'s Q4 2021 filing shows 276 new, 121 increased, 95 reduced and 168 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 166,431 shares worth $79M. The largest sale was Tesla, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

  • Caxton Associates (New York)'s largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 166,431 shares worth $79M.
  • Caxton Associates (New York) added most to Pfizer in Q4 2021, an estimated $45.1M increase.
  • Caxton Associates (New York)'s biggest Q4 2021 reduction was Tesla, cutting an estimated $179M.
  • Caxton Associates (New York) fully exited Aptiv in Q4 2021, selling an estimated $89.5M.
  • Caxton Associates (New York)'s ten largest holdings make up 45% of its $982M portfolio in Q4 2021.
  • Caxton Associates (New York) opened 276 new positions and closed 168 in Q4 2021.
  • Caxton Associates (New York)'s portfolio value rose 8.5% quarter-over-quarter to $982M.

Based on Caxton Associates (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.